MedTrace Logo

Scaling up Evidence Based MNCH Interventions : A Quasi Experimental Study Umeed e Nau (UeN) Project

NCT04184544 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5000000

Last updated 2021-09-01

No results posted yet for this study

Summary

The Umeed-e-Nau (UeN) initiative aims to support the introduction, scale up, and further piloting of high quality and high impact interventions to improve Maternal, Newborn And Child Health (MNCH)in Pakistan by harnessing the potential of both public and private sectors, coupled with introduction of women and girls empowerment interventions. UeN has two major components: 1) Introducing proven effective MNCH interventions at scale in 8 rural districts of Pakistan, and 2) Generating evidence on innovative approaches to improve MNCH while included in public health programs in Pakistan. There are six trials that are being conducted to address different evidences gaps to improve maternal, newborn and child health in Pakistan. The protocols of the trials will be registered separately.

Conditions

  • Maternal Complication of Pregnancy
  • Newborn Morbidity
  • Perinatal Problems

Interventions

OTHER

Improving of quality of care at health facility and outreach level

Community Mobilization and engagement; Use of DHIS data for decision making; Capacity building of health care workers and providers and other Community level and facility level interventions to improve MNCH outcomes

Sponsors & Collaborators

  • Bill and Melinda Gates Foundation

    collaborator OTHER

  • The Hospital for Sick Children

    collaborator OTHER

  • Aga Khan University

    lead OTHER

Principal Investigators

  • Zulfiqar A Bhutta, PhD · AKU

Study Design

Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
FACTORIAL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-03-01
Primary Completion
2022-12-31
Completion
2023-06-30

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04184544 on ClinicalTrials.gov